Platelet degranulation and glycoprotein IIbIIIa opening are not related to bleeding phenotype in severe haemophilia A patients

Thrombosis and Haemostasis

Volumn 111, Issue 6, 2014, Pages 1022-1030

  van Bladel, Esther R ^a   Schutgens, Roger E G ^a,b   Fischer, Kathelijn ^b   de Groot, Philip G ^a   Roest, Mark ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical phenotype; GPIIbIIIa; Haemophilia A; P selectin; Platelet reactivity

Indexed keywords

15 HYDROXY 11ALPHA, 9ALPHA EPOXYMETHANOPROSTA 5, 13 DIENOIC ACID; BLOOD CLOTTING FACTOR 8; FIBRINOGEN RECEPTOR; ILOPROST; PADGEM PROTEIN; RANTES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; CELL ACTIVATION; CHILD; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PLATELET DEGRANULATION; PLATELET RESPONSIVENESS; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION AND CHARACTERISTICS; ADOLESCENT; BLOOD; COHORT ANALYSIS; DEGRANULATION; HEMARTHROSIS; MALE; METABOLISM; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD PLATELETS; CELL DEGRANULATION; COHORT STUDIES; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; PHENOTYPE; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84901934218     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-07-0546     Document Type: Article

References (16)

1. Van Dijk K, Fischer K, Van der Bom JG, et al. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. Haemophilia 2005; 11: 438-443.
2. den Uijl IEM, Fischer K, Van Der Bom JG, et al. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia. Haemophilia 2009; 15: 83-90.
3. White GC, Rosendaal F, Aledort LM, et al. Definitions in haemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560.
4. Rainsford SG, Hall A. A three-year study of adolescent boys suffering from haemophilia and allied disorders. Br J Haematol 1973; 24: 539-551.
5. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-399.
6. Molho P, Rolland N, Lebrun T, et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. Haemophilia 2000; 6: 23-32.
7. van Dijk K, van der Bom JG, Fischer K, et al. Phenotype of severe haemophilia A and plasma levels of risk factors for thrombosis. J Thromb Haemost 2007; 5: 1062-1064.
8. van Dijk K, van der Bom JG, Lenting PJ, et al. Factor VIII half-life and clinical phenotype of severe haemophilia A. Haematologica 2005; 90: 494-498.
9. van Bladel ER, Roest M, de Groot PG, et al. Up-regulation of platelet activation in haemophilia A. Haematologica 2011; 96: 888-895.
10. Schulman S, Eelde A, Holmstrom M, et al. Validation of a composite score for clinical severity of haemophilia. J Thromb Haemost 2008; 6: 1113-1121.
11. Borchiellini A, Fijnvandraat K, ten Cate JW, et al. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 1996; 88: 2951-2958.
12. Hulstein JJ, de Groot PG, Silence K, et al. A novel nanobody that detects the gain-offunction phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 2005; 106: 3035-3042.
13. Lankhof H, Damas C, Schiphorst ME, et al. Functional studies on platelet adhesion with recombinant von Willebrand Factor Type 2B mutants R543Q and R543W under conditions of flow. Blood 1997; 89: 2766-2772.
14. Wartiovaara-Kautto U, Joutsi-Korhonen L, Ilveskero S, et al. Platelets significantly modify procoagulant activities in haemophilia A. Haemophilia 2011; 17: 743-751.
15. Hoffman M, Monroe DM. Low intensity laser therapy speeds wound healing in haemophilia by enhancing platelet procoagulant activity. Wound Repair Regen 2012; 20: 770-777.
16. Teyssandier M, Delignat S, Rayes J, et al. Activation state of platelet in experimental severe haemophilia A. Haematolgica 2012; 97: 1115-1116.